K
Katy J.L. Bell
Researcher at University of Sydney
Publications - 136
Citations - 3024
Katy J.L. Bell is an academic researcher from University of Sydney. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 22, co-authored 106 publications receiving 1895 citations. Previous affiliations of Katy J.L. Bell include Bond University & Westmead Hospital.
Papers
More filters
Journal ArticleDOI
Patient Preferences for Follow-up After Recent Excision of a Localized Melanoma.
Wei Yin Lim,Wei Yin Lim,Rachael L. Morton,Robin M. Turner,Marisa C. Jenkins,Pascale Guitera,Pascale Guitera,Les Irwig,Angela C Webster,Mbathio Dieng,Robyn P. M. Saw,Robyn P. M. Saw,Donald Low,Cynthia Low,Katy J.L. Bell,Katy J.L. Bell +15 more
TL;DR: Some patients with melanoma may prefer fewer scheduled visits, if they are supported to do SSE and there is rapid clinical review of anything causing concern (patient-led surveillance).
Journal ArticleDOI
Mixed models showed no need for initial response monitoring after starting antihypertensive therapy.
Katy J.L. Bell,Andrew Hayen,Petra Macaskill,Jonathan C. Craig,Jonathan C. Craig,Bruce Neal,Les Irwig +6 more
TL;DR: In this paper, mixed models were used to analyze data from the Perindopril Protection Against Recurrent Stroke Study (PROGRESS), which examined the effects of perindopolril and indapamide in 6,105 patients at high risk of a cerebrovascular event.
Journal ArticleDOI
Legacy effects of statins on cardiovascular and all-cause mortality: a meta-analysis.
Agnish Nayak,Andrew Hayen,Lin Zhu,Kevin McGeechan,Paul Glasziou,Les Irwig,Jenny Doust,Gabriel Andrew Gregory,Katy J.L. Bell +8 more
TL;DR: Possible post-trial statin legacy effects on all-cause mortality appear to be driven by the primary prevention studies, although these relative benefits were smaller than those observed within the trial, the absolute benefits may be similar for the two time periods.
Journal ArticleDOI
The potential value of monitoring bone turnover markers among women on alendronate
Katy J.L. Bell,Andrew Hayen,Les Irwig,Marc C. Hochberg,Kristine E. Ensrud,Steven R. Cummings,Douglas C. Bauer +6 more
TL;DR: Although bone turnover markers appear promising for monitoring between‐person differences in response to treatment, their use in clinical practice is currently limited by large random within‐person variation.
Journal ArticleDOI
Potential Usefulness of BMD and Bone Turnover Monitoring of Zoledronic Acid Therapy Among Women With Osteoporosis: Secondary Analysis of Randomized Controlled Trial Data.
Katy J.L. Bell,Andrew Hayen,Paul Glasziou,Les Irwig,Richard Eastell,Stephanie L. Harrison,Dennis M. Black,Douglas C. Bauer +7 more
TL;DR: Serum PINP is potentially useful in monitoring response to zoledronic acid and further research is needed to evaluate the effects of monitoring PINP on treatment decisions and other clinically relevant outcomes.